Stockreport

Thryv Therapeutics to Present Results of Wave I Part 1 Clinical Study at American College of Cardiology Conference in Atlanta, Georgia on April 7th, 2024 [Yahoo! Finance]

Thryv Holdings, Inc.  (THRY) 
PDF Larger treatment effects seen in pre-defined subgroups of individuals with largest increases in QTc from baseline and longest QTc intervals. No meaningful safety find [Read more]